CD4 and lymphoma: B and CD4+ T cells play essential roles in viral clearance; thus, patients with lymphoma patients, who have B and CD4+ T cell deficiencies, are unable to effectively and rapidly clear SARS-CoV-2, leading to a higher risk of disease exacerbation or death.